1. Report Introduction 2. Benign prostatic hyperplasia (BPH) Epidemiology Overview at a Glance 2.1. Patient Share Distribution of Benign prostatic hyperplasia (BPH) in 2017 2.2. Patient Share Distribution of Benign prostatic hyperplasia (BPH) in 2027 3. Disease Background and Overview: Benign prostatic hyperplasia (BPH) 3.1. Introduction 3.2. Symptoms 3.3. Etiology 3.4. Risk Factors 3.5. Pathophysiology 3.6. Diagnosis 3.7. Treatment 4. Epidemiology and Patient Population 4.1. Key Findings 4.2. Total Prevalent/ Incident Patient Population of Benign prostatic hyperplasia (BPH) in 7MM 4.3. Total Prevalent/ Incident Patient Population of Benign prostatic hyperplasia (BPH) in 7MM – By Countries 5. Epidemiology of Benign prostatic hyperplasia (BPH) by Countries 5.1. United States 5.1.1. Assumptions and Rationale 5.1.2. Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) 5.1.3. Sub-Type Specific cases of the Benign prostatic hyperplasia (BPH) * 5.1.4. Sex- Specific Cases of the Benign prostatic hyperplasia (BPH)* 5.1.5. Diagnosed Cases of the Benign prostatic hyperplasia (BPH) 5.2. EU5 5.3. Assumptions and Rationale 5.4. Germany 5.4.1. Assumptions and Rationale 5.4.2. Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) 5.4.3. Sub-Type Specific cases of the Benign prostatic hyperplasia (BPH)* 5.4.4. Sex- Specific Cases of the Benign prostatic hyperplasia (BPH)* 5.4.5. Diagnosed Cases of the Benign prostatic hyperplasia (BPH) 5.5. France 5.5.1. Assumptions and Rationale 5.5.2. Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) 5.5.3. Sub-Type Specific cases of the Benign prostatic hyperplasia (BPH)* 5.5.4. Sex- Specific Cases of the Benign prostatic hyperplasia (BPH)* 5.5.5. Diagnosed Cases of the Benign prostatic hyperplasia (BPH) 5.6. Italy 5.6.1. Assumptions and Rationale 5.6.2. Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) 5.6.3. Sub-Type Specific cases of the Benign prostatic hyperplasia (BPH)* 5.6.4. Sex- Specific Cases of the Benign prostatic hyperplasia (BPH)* 5.6.5. Diagnosed Cases of the Benign prostatic hyperplasia (BPH) 5.7. Spain 5.7.1. Assumptions and Rationale 5.7.2. Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) 5.7.3. Sub-Type Specific cases of the Benign prostatic hyperplasia (BPH)* 5.7.4. Sex- Specific Cases of the Benign prostatic hyperplasia (BPH)* 5.7.5. Diagnosed Cases of the Benign prostatic hyperplasia (BPH) 5.8. United Kingdom 5.8.1. Assumptions and Rationale 5.8.2. Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) 5.8.3. Sub-Type Specific cases of the Benign prostatic hyperplasia (BPH)* 5.8.4. Sex- Specific Cases of the Benign prostatic hyperplasia (BPH)* 5.8.5. Diagnosed Cases of the Benign prostatic hyperplasia (BPH) 5.9. Japan 5.9.1. Assumptions and Rationale 5.9.2. Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) 5.9.3. Sub-Type Specific cases of the Benign prostatic hyperplasia (BPH)* 5.9.4. Sex- Specific Cases of the Benign prostatic hyperplasia (BPH)* 5.9.5. Diagnosed Cases of the Benign prostatic hyperplasia (BPH) 6. Unmet Needs of the Benign prostatic hyperplasia (BPH) 7. Appendix 8. Report Methodology 8.1. Sources 9. DelveInsight Capabilities 10. Disclaimer 11. About DelveInsight *Indication Specific

Table 1: Total Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) in 7MM Table 2: Total Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) in 7MM by Countries Table 3: Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) in United States (2016-2027) Table 4: Sub-Type Specific cases of the Benign prostatic hyperplasia (BPH) in United States (2016-2027)* Table 5: Sex- Specific Cases of the Benign prostatic hyperplasia (BPH) in United States (2016-2027)* Table 6: Diagnosed Cases of the Benign prostatic hyperplasia (BPH) in United States (2016-2027) Table 7: Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) in Germany (2016-2027) Table 8: Sub-Type Specific cases of the Benign prostatic hyperplasia (BPH) in Germany (2016-2027) * Table 9: Sex- Specific Cases of the Benign prostatic hyperplasia (BPH) in Germany (2016-2027) * Table 10: Diagnosed Cases of the Benign prostatic hyperplasia (BPH) in Germany (2016-2027) Table 11: Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) in France (2016-2027) Table 12: Sub-Type Specific cases of the Benign prostatic hyperplasia (BPH) in France (2016-2027) * Table 13: Sex- Specific Cases of the Benign prostatic hyperplasia (BPH) in France (2016-2027) * Table 14: Diagnosed Cases of the Benign prostatic hyperplasia (BPH) in France (2016-2027) Table 15: Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) in Italy (2016-2027) Table 16: Sub-Type Specific cases of the Benign prostatic hyperplasia (BPH) in Italy (2016-2027) * Table 17: Sex- Specific Cases of the Benign prostatic hyperplasia (BPH) in Italy (2016-2027) * Table 18: Diagnosed Cases of the Benign prostatic hyperplasia (BPH) in Italy (2016-2027) Table 19: Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) in Spain (2016-2027) Table 20: Sub-Type Specific cases of the Benign prostatic hyperplasia (BPH) in Spain (2016-2027) * Table 21: Sex- Specific Cases of the Benign prostatic hyperplasia (BPH) in Spain (2016-2027) * Table 22: Diagnosed Cases of the Benign prostatic hyperplasia (BPH) in Spain (2016-2027) Table 23: Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) in UK (2016-2027) Table 24: Sub-Type Specific cases of the Benign prostatic hyperplasia (BPH) in UK (2016-2027) * Table 25: Sex- Specific Cases of the Benign prostatic hyperplasia (BPH) in UK (2016-2027) * Table 26: Diagnosed Cases of the Benign prostatic hyperplasia (BPH) in UK (2016-2027) Table 27: Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) in Japan (2016-2027) Table 28: Sub-Type Specific cases of the Benign prostatic hyperplasia (BPH) in Japan (2016-2027) * Table 29: Sex- Specific Cases of the Benign prostatic hyperplasia (BPH) in Japan (2016-2027) * Table 30: Diagnosed Cases of the Benign prostatic hyperplasia (BPH) in Japan (2016-2027) Table 1: Total Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) in 7MM Table 2: Total Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) in 7MM by Countries Table 3: Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) in United States (2016-2027) Table 4: Sub-Type Specific cases of the Benign prostatic hyperplasia (BPH) in United States (2016-2027)* Table 5: Sex- Specific Cases of the Benign prostatic hyperplasia (BPH) in United States (2016-2027)* Table 6: Diagnosed Cases of the Benign prostatic hyperplasia (BPH) in United States (2016-2027) Table 7: Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) in Germany (2016-2027) Table 8: Sub-Type Specific cases of the Benign prostatic hyperplasia (BPH) in Germany (2016-2027) * Table 9: Sex- Specific Cases of the Benign prostatic hyperplasia (BPH) in Germany (2016-2027) * Table 10: Diagnosed Cases of the Benign prostatic hyperplasia (BPH) in Germany (2016-2027) Table 11: Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) in France (2016-2027) Table 12: Sub-Type Specific cases of the Benign prostatic hyperplasia (BPH) in France (2016-2027) * Table 13: Sex- Specific Cases of the Benign prostatic hyperplasia (BPH) in France (2016-2027) * Table 14: Diagnosed Cases of the Benign prostatic hyperplasia (BPH) in France (2016-2027) Table 15: Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) in Italy (2016-2027) Table 16: Sub-Type Specific cases of the Benign prostatic hyperplasia (BPH) in Italy (2016-2027) * Table 17: Sex- Specific Cases of the Benign prostatic hyperplasia (BPH) in Italy (2016-2027) * Table 18: Diagnosed Cases of the Benign prostatic hyperplasia (BPH) in Italy (2016-2027) Table 19: Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) in Spain (2016-2027) Table 20: Sub-Type Specific cases of the Benign prostatic hyperplasia (BPH) in Spain (2016-2027) * Table 21: Sex- Specific Cases of the Benign prostatic hyperplasia (BPH) in Spain (2016-2027) * Table 22: Diagnosed Cases of the Benign prostatic hyperplasia (BPH) in Spain (2016-2027) Table 23: Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) in UK (2016-2027) Table 24: Sub-Type Specific cases of the Benign prostatic hyperplasia (BPH) in UK (2016-2027) * Table 25: Sex- Specific Cases of the Benign prostatic hyperplasia (BPH) in UK (2016-2027) * Table 26: Diagnosed Cases of the Benign prostatic hyperplasia (BPH) in UK (2016-2027) Table 27: Prevalent/Incident Cases of the Benign prostatic hyperplasia (BPH) in Japan (2016-2027) Table 28: Sub-Type Specific cases of the Benign prostatic hyperplasia (BPH) in Japan (2016-2027) * Table 29: Sex- Specific Cases of the Benign prostatic hyperplasia (BPH) in Japan (2016-2027) * Table 30: Diagnosed Cases of the Benign prostatic hyperplasia (BPH) in Japan (2016-2027)